Core Viewpoint - Microchip Biotech (688321.SH) has received a decision from the National Intellectual Property Administration of the People's Republic of China, declaring the company's patent for a specific compound and its medicinal applications completely invalid [1] Summary by Relevant Sections - Patent Invalidity - The National Intellectual Property Administration reviewed a request for invalidation submitted by Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. regarding Microchip Biotech's patent titled "A type E benzamide compound and its medicinal formulation and application" (Patent No.: ZL201410136761.X) [1]